Patient-reported Quality of Life and Satisfaction With Cosmetic Outcomes After Breast Conservation and Mastectomy With and Without Reconstruction: Results of a Survey of Breast Cancer Survivors

Reshma Jagsi, Yun Li, Monica Morrow, Nancy Janz, Amy Alderman, John Graff, Ann Hamilton, Steven Katz, Sarah Hawley, Reshma Jagsi, Yun Li, Monica Morrow, Nancy Janz, Amy Alderman, John Graff, Ann Hamilton, Steven Katz, Sarah Hawley

Abstract

Objective: Although breast conservation is therapeutically equivalent to mastectomy for most patients with early-stage breast cancer, an increasing number of patients are pursuing mastectomy, which may be followed by breast reconstruction. We sought to evaluate long-term quality of life and cosmetic outcomes after different locoregional management approaches, as perceived by patients themselves.

Methods: We surveyed women with a diagnosis of nonmetastatic breast cancer from 2005 to 2007, as reported to the Los Angeles and Detroit population-based Surveillance, Epidemiology, and End Results registries. We received responses from 2290 women approximately 9 months after diagnosis (73% response rate) and from 1536 of these 4 years later. We evaluated quality of life and patterns and correlates of satisfaction with cosmetic outcomes overall and, more specifically, within the subgroup undergoing mastectomy with reconstruction, using multivariable linear regression.

Results: Of the 1450 patients who responded to both surveys and experienced no recurrence, 963 underwent breast-conserving surgery, 263 mastectomy without reconstruction, and 222 mastectomy with reconstruction. Cosmetic satisfaction was similar between those receiving breast conservation therapy and those receiving mastectomy with reconstruction. Among patients receiving mastectomy with reconstruction, reconstruction type and radiation receipt were associated with satisfaction (P < 0.001), with an adjusted scaled satisfaction score of 4.7 for patients receiving autologous reconstruction without radiation, 4.4 for patients receiving autologous reconstruction and radiation therapy, 4.1 for patients receiving implant reconstruction without radiation therapy, and 2.8 for patients receiving implant reconstruction and radiation therapy.

Conclusions: Patient-reported cosmetic satisfaction was similar after breast conservation and after mastectomy with reconstruction. In patients undergoing postmastectomy radiation, the use of autologous reconstruction may mitigate the deleterious impact of radiation on cosmetic outcomes.

Figures

Figure 1
Figure 1
Patient Flow into the Study. This figure depicts the flow of patients into the study from those initially identified to the final analytic sample.
Figure 2. Satisfaction with Breast Cosmetic Outcomes…
Figure 2. Satisfaction with Breast Cosmetic Outcomes by Surgery Type
This figure depicts adjusted scores on the scaled measure of satisfaction with breast cosmetic outcomes by type of surgery received, based on results from the model described in Table 3. Error bars represent 95% confidence intervals in comparison to the reference group (breast conserving therapy). Satisfaction with breast cosmetic outcomes was measured by an interval scale derived the mean of 6 items, as described more fully in the methods section. Mean (SD) of the scale was 3.33 (1.02), with a minimum of 1 and maximum of 5. Cronbach's alpha was 0.90.
Figure 3. Satisfaction with Outcomes of Breast…
Figure 3. Satisfaction with Outcomes of Breast Reconstruction by Reconstruction Type and Receipt of Radiation Therapy*
This figure depicts adjusted scores on the scaled measure of satisfaction with reconstruction outcomes, as measured in patients receiving breast reconstruction with various approaches, based on results from the model described in Table 4. Error bars represent 95% confidence intervals in comparison to the reference group (implant no radiation). Satisfaction with reconstruction outcomes was measured by an interval scale derived the mean of 5 items, as described more fully in the methods section. Mean (SD) of the scale was 3.64 (SD 1.27), with a minimum of 1 and maximum of 5. Cronbach's alpha was 0.91.

Source: PubMed

3
Subscribe